Table 1 Diagnosis-related non-anthroposophic therapies in months 0–6
Main diagnosis (International Classification of Diseases, Tenth Edition) | Non-anthroposophic therapies | Patients with therapy | Â | |
|---|---|---|---|---|
| Â | Drugs (Anatomical Therapeutic Chemical Classification Index) | Non-medication | N | % |
Mental disorders (F00–F99) | Antiepileptic, psycholeptic, analeptic, and anti-addiction drugs (N03A, N05–06, N07B) | Occupational therapy, play therapy | 31/175 | 17.7% |
Respiratory disorders (J00–J99) | Respiratory drugs (H02, J01–02, J04–05, J07A, L03, R01, R03, R06–07), | Relevant surgery | 18/52 | 34.6% |
Musculoskeletal diseases (M00–M99) | Immunosuppressive, musculoskeletal, analgesic, and antidepressant drugs (L04, M01–05, M09, N02A-B, N06A) | Physiotherapy, relevant surgery | 3/16 | 18.8% |
Headache disorders (G43–G44, R51) | Analgesics, antimigraine drugs, antidepressants (C04AX01, C07AA05, C07AB02, C08CA06, C08DA01, N02, N03AG01, N06A, N07CA03) |  | 0/17 | 0.0% |
Urinary incontinence (R32) | Vasopressin and analogues (H01BA) | Alarm therapy, occupational therapy, play therapy | 1/36 | 2.8% |
Total (evaluable patients) | Â | Â | 53/296 | 17.9% |